Introduction
Neurodegenerative disorders such as Alzheimer disease (AD), Parkinson disease (PD), Frontotemporal dementias (FTDs), Huntington disease (HD), Amyotrophic Lateral Sclerosis (ALS), and Spinocerebellar Ataxias (SCAs) are common causes of morbidity and premature mortality. Incidence of the most common and debilitating neurodegenerative diseases is strongly age-related. This is true also for the less common Mendelian forms of AD, PD, FTDs, and ALS, as these variants exhibit age-related penetrance. Similarly, HD and SCAs exhibit age-related penetrance. With the number of elderly individuals now rising dramatically in both developed and developing nations, prevalence of neurodegenerative diseases is expected to soar. Efforts to find disease-modifying treatments have been largely unsuccessful. These efforts focus mainly on identifying pathogenic mechanisms specific to each disease process. The relative lack of progress with these approaches and the age-related nature of neurodegenerative disease incidence suggests that modulation of aging per se may be a useful alternative approach for delaying the onset or retarding the progression of neurodegenerative diseases Neurobiology of Disease 85 (2016) 73-80 
